Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akari, Astrazeneca, Glaxosmithkline, Mereo, Orpheris, Ovid, Redhill, Takeda, Union, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Neurometrix, Sherlock Biosciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alimera, Annovis, Aptevo, Arena, Astrazeneca, Biophytis, BMS, Cartesian, Clear Creek, Genfit, Hepion, Immunomic, Innovent, Iveric, Kuros, Orchard, Oxurion, Sanofi, Transcenta.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Onduo.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acasti, Akari, Axsome, Bluebird, Eiger, Embera, GSK, Imbrium, Kiadis, Maat, Mirum, NGM, Novan, Novartis, Orpheris, Provention, Regenerx, Shattuck, VBI, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adaptimmune, Arrowhead, Assembly, Daiichi Sankyo, Enanta, Fortress, Idorsia, Janssen, Matinas, Treadwell, Viking.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Carl Zeiss Meditech, Eurofins, Tandem Diabetes Care.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Applied Molecular Transport, Axcella, Cognition, Cymabay, Durect, Intercept, Mycovia, Oncosec, Onxeo, Redhill, Urogen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Sight Sciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Pharma, Cardiol, Cerecor, Dermavant, Mycovia, Novartis, Oncolytics, Oncology Venture, Outlook, Silverback.